✦ LIBER ✦

Surgical adjuvant therapy of malignant melanoma with Corynebacterium parvum

✍ Scribed by Elias Y. Hilal; Carl M. Pinsky; Yashar Hirshaut; Harold J. Wanebo; John A. Hansen; David W. Braun Jr; Joseph G. Fortner; Herbert F. Oettgen

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 622 KB
Volume: 48
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810715)48:2<245::aid-cncr2820480206>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corynebacterium parvum versus BCG adjuva

Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma

✍ Allan Lipton; Harold A. Harvey; Bellarmine Lawrence; Robert Gottlieb; Miodrag Ku 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 1 views

Surgical therapy for distant metastases

Surgical therapy for distant metastases of malignant melanoma

✍ Thomas Meyer; Susanne Merkel; Jonas Goehl; Werner Hohenberger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 3 views

Current management of melanoma: Benefits

Current management of melanoma: Benefits of surgical staging and adjuvant therapy

✍ Kelly M. McMasters; Susan M. Swetter 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Cyclophosphamide plus 5-(3,3-dimethyl-1-

Cyclophosphamide plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) with or without corynebacterium parvum in metastatic malignant melanoma

✍ Cary A. Presant; Alfred A. Bartolucci; Richard V. Smalley; W. Ralph Vogler 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Adjuvant treatment of malignant melanoma

Adjuvant treatment of malignant melanoma with DTIC + estracyt or BCG

✍ Dr. Constantine P. Karakousis; Lawrence J. Emrich 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

Eighty-two patients with invasive malignant melanoma and no distant metastases were prospectively randomized following their surgical treatment to 1) observation; 2) chemotherapy with Dacarbazine (DTIC) 200 mg/M2 I.V. daily X 5 every 4 weeks and Estracyt 15 mg/kg orally daily for 1 year; and 3) immu

Radiofrequency hyperthermia as adjuvant

Radiofrequency hyperthermia as adjuvant therapy following surgical resection of an experimental malignant neoplasm

✍ Richard Dalfen; Kevin Calhoun; Tom Gilas; Tina Mathews; Michael Falk; Frederick 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB